Expand chart
Data: Company documents; Chart: Andrew Witherspoon/Axios

Over the past 4 years, the product that generated the most sales for Pfizer wasn't one of its household names, like Lyrica, Lipitor or Viagra. It was Prevnar 13, a vaccine that protects against pneumonia and other infections.

The bottom line: Pfizer has collected $23.4 billion in Prevnar 13 sales since 2015, including $5.8 billion last year. The pharmaceutical giant got a big revenue boost in 2015, after the federal government recommended the vaccine for people older than 65 and required insurance to cover it.

Details: Before 2015, most of Pfizer's Prevnar 13 revenue came from international markets.

  • But the seal of approval from the Centers for Disease Control and Prevention in late 2014 prompted U.S. seniors to get the vaccine, which most commonly was given to children younger than 2.
  • Pfizer commands higher prices for the drug in the U.S. The price of a single Prevnar 13 shot this year, before taking out rebates and discounts, is about $195 — a 5% increase from 2018 and 79% higher than its list price from 2010.
  • The patent for Prevnar 13 doesn't expire until 2026, several years after some of Pfizer's other growing medications, like Ibrance and Xeljanz, will have lost their patent protection. (Lyrica, Lipitor and Viagra are already off-patent.)

Go deeper: The rising price of the pneumococcal vaccine is angering doctors, Kaiser Health News reports.

Go deeper

Updated 9 mins ago - Politics & Policy

Supreme Court rejects request to extend Wisconsin absentee ballot deadline

Photo: Saul Loeb/AFP via Getty Images

The Supreme Court rejected in a 5-3 decision Monday Wisconsin Democrats' request to reinstate an extension of the deadline for counting absentee ballots to six days after Election Day, as long as they're postmarked by Nov. 3.

Why it matters: All ballots must now be received by 8 p.m. on Election Day in Wisconsin, a critical swing state in the presidential election.

Senate confirms Amy Coney Barrett to the Supreme Court

Judge Amy Coney Barrett before a meeting on Capitol Hill on Oct. 21. Photo: Sarah Silbiger/pool/AFP via Getty Images

The Senate voted 52-48 on Monday to confirm Judge Amy Coney Barrett to the Supreme Court. She is expected to be sworn in within hours.

Why it matters: President Trump and Senate Republicans have succeeded in confirming a third conservative justice in just four years, tilting the balance of the Supreme Court firmly to the right for perhaps a generation.

Updated 48 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Politics: The swing states where the pandemic is raging — Pence no longer expected to attend Barrett confirmation vote after COVID exposure.
  2. Health: 13 states set single-day case records last week
  3. Business: Where stimulus is needed most.
  4. Education: The dangerous instability of school re-openings.
  5. World: Restrictions grow across Europe.
  6. Media: Fox News president and several hosts advised to quarantine.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!